As the United States stock market kicks off February with a rise in major indices like the Dow Jones and S&P 500, investors are keeping a close watch on economic indicators and geopolitical developments that could impact market dynamics. In this environment of fluctuating oil prices and evolving monetary policy, identifying high-growth tech stocks involves assessing companies' ability to innovate and adapt amidst changing economic conditions.

Top 10 High Growth Tech Companies In The United States

Name	Revenue Growth	Earnings Growth	Growth Rating
Marker Therapeutics	62.86%	62.39%	★★★★★★
Palantir Technologies	25.85%	29.91%	★★★★★★
Workday	10.74%	28.15%	★★★★★☆
Procore Technologies	11.49%	60.07%	★★★★★☆
Cellebrite DI	15.29%	20.24%	★★★★★☆
Sandisk	28.21%	47.34%	★★★★★★
Zscaler	15.86%	45.93%	★★★★★☆
Circle Internet Group	24.51%	85.21%	★★★★★☆
Viridian Therapeutics	46.29%	51.51%	★★★★★☆
Duos Technologies Group	53.76%	155.11%	★★★★★☆

Let's explore several standout options from the results in the screener.

Veracyte (VCYT)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Veracyte, Inc. is a diagnostics company that operates both in the United States and internationally, with a market capitalization of $3.01 billion.

Operations: Veracyte generates revenue primarily through its Diagnostic Products and Biopharmaceutical Services, totaling $495.14 million. The company focuses on providing advanced diagnostic solutions both domestically and internationally.

Veracyte's recent financial performance and strategic initiatives underscore its emerging role in high-growth tech sectors. With a notable 22.4% annual earnings growth forecast, the company outpaces the US market average of 15.7%. This growth is complemented by a robust R&D focus, evidenced by its innovative Afirma GRID platform, which is pivotal in advancing thyroid cancer diagnostics. Recent guidance predicts revenue to reach up to $582 million by 2026, marking significant year-over-year growth. Moreover, Veracyte's presentations at major healthcare conferences highlight its active engagement with the medical community and commitment to leveraging technology for enhanced diagnostic accuracy, potentially reshaping patient management in oncology.

monday.com (MNDY)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: monday.com Ltd. develops software applications globally, with operations in the United States, Europe, the Middle East, Africa, and the United Kingdom; it has a market cap of $5.92 billion.

Operations: monday.com Ltd. generates revenue primarily through its Internet Software & Services segment, totaling $1.17 billion. The company operates internationally across several regions, including the United States and Europe.

Monday.com's recent strategic partnerships and robust financial performance underscore its potential within the tech sector. By becoming the Official Global Work Management Partner for the Bonds Flying Roos, monday.com is set to enhance operational efficiencies across high-stakes, global competitions—a move that aligns with its AI-driven platform capabilities. Financially, the company has shown significant momentum: Q3 sales surged to $316.86 million from $251 million year-over-year, while net income flipped from a loss of $12.03 million to a gain of $13.05 million in the same period. This growth trajectory is supported by an impressive annual revenue forecast increase of 26%, projecting up to $1,228 million by year-end. Such developments not only demonstrate monday.com’s effective scale-up but also its increasing indispensability in complex project management scenarios worldwide.

Zeta Global Holdings (ZETA)

Simply Wall St Growth Rating: ★★★★★☆

Overview: Zeta Global Holdings Corp. operates an omnichannel data-driven cloud platform offering consumer intelligence and marketing automation software to enterprises globally, with a market cap of approximately $4.57 billion.

Operations: The company generates revenue primarily from its Internet Software & Services segment, amounting to $1.22 billion.

Zeta Global Holdings, a contender in the tech arena, has been actively enhancing its market position through significant conference presentations and strategic equity offerings. Recently, the company revised its revenue guidance upward for 2026 to at least $1.73 billion, reflecting a robust year-over-year growth of 34%, highlighting its dynamic response to evolving market demands. This adjustment is partly propelled by the integration of Marigold's enterprise software business, which alone is expected to contribute significantly to the annual revenue stream. Moreover, Zeta's commitment to innovation is evident from its R&D spending trends that align with industry standards for fostering growth in software and AI technologies. By repurchasing shares worth $26.91 million recently, Zeta not only returns value to shareholders but also reaffirms confidence in its financial health and future prospects.

Turning Ideas Into Actions

• Click through to start exploring the rest of the 71 US High Growth Tech and AI Stocks now.
• Invested in any of these stocks? Simplify your portfolio management with Simply Wall St and stay ahead with our alerts for any critical updates on your stocks.
• Take control of your financial future using Simply Wall St, offering free, in-depth knowledge of international markets to every investor.

Curious About Other Options?

• Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
• Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.
• Find companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.